person · Reporting owner

Mulato James

Disclosed activity across 1 company

Tapewire entity: 37540
SEC CIK: 0001693402

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ASTRONICS CORPATRO · Entity 4200	Pres Astronics Test Systems	September 30, 2026	October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ASTRONICS CORP

Report date September 30, 2026 · Filed October 03, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
$.01 PV Com StkSEC Table I · non-derivative	Direct	36,331.822	Reported balance After 2026-09-30 transaction · row 1 1 source row Row 1 · 2026-09-30 · Grant · Acquired 555 · Balance 36,331.822 F1: Acquired shares via exercise of subscription agreement under Employee Stock Purchase Plan.
$.01 PV CL B STKSEC Table I · non-derivative	Direct	10,209	Reported balance After 2026-09-30 transaction · row 2 1 source row Row 2 · 2026-09-30 · Grant · Acquired 111 · Balance 10,209 F1: Acquired shares via exercise of subscription agreement under Employee Stock Purchase Plan.
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $26.47 · Expires 2026-12-14	Direct	6,560	Reported balance Holding disclosure · report date 2026-09-30 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 6,560
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $26.47 · Expires 2026-12-14	Direct	2,492	Reported balance Holding disclosure · report date 2026-09-30 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 2,492
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $29.68 · Expires 2027-12-12	Direct	7,950	Reported balance Holding disclosure · report date 2026-09-30 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 7,950
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $29.68 · Expires 2027-12-12	Direct	3,021	Reported balance Holding disclosure · report date 2026-09-30 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 3,021
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $26.31 · Expires 2028-12-13	Direct	11,570	Reported balance Holding disclosure · report date 2026-09-30 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 11,570
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $26.31 · Expires 2028-12-13	Direct	2,314	Reported balance Holding disclosure · report date 2026-09-30 · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · Balance 2,314
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $25.03 · Expires 2029-12-09	Direct	18,150	Reported balance Holding disclosure · report date 2026-09-30 · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · Balance 18,150
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $25.03 · Expires 2029-12-09	Direct	3,630	Reported balance Holding disclosure · report date 2026-09-30 · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · Balance 3,630
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.04 · Expires 2031-01-22	Direct	27,000	Reported balance Holding disclosure · report date 2026-09-30 · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · Balance 27,000
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.04 · Expires 2031-01-21	Direct	5,400	Reported balance Holding disclosure · report date 2026-09-30 · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · Balance 5,400
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $9.28 · Expires 2031-12-09	Direct	32,700	Reported balance Holding disclosure · report date 2026-09-30 · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · Balance 32,700
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $9.28 · Expires 2031-12-09	Direct	6,540	Reported balance Holding disclosure · report date 2026-09-30 · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · Balance 6,540
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.12 · Expires 2032-12-16	Direct	35,600	Reported balance Holding disclosure · report date 2026-09-30 · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · Balance 35,600
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.12 · Expires 2032-12-16	Direct	7,120	Reported balance Holding disclosure · report date 2026-09-30 · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · Balance 7,120
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.63 · Expires 2033-12-07	Direct	8,300	Reported balance Holding disclosure · report date 2026-09-30 · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · Balance 8,300
OptionSEC Table II · derivative / convertible security · Conversion / exercise price $12.63 · Expires 2033-12-07	Direct	1,660	Reported balance Holding disclosure · report date 2026-09-30 · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · Balance 1,660
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	18,550	Reported balance Holding disclosure · report date 2026-09-30 · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · Balance 18,550 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024- December 31, 2026. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 22, 2027, with the vesting percentage determined based on actual performance.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	3,710	Reported balance Holding disclosure · report date 2026-09-30 · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · Balance 3,710 F4: Each restricted stock unit represents the right to receive, at settlement, one share of class B stock. F3: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024- December 31, 2026. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 22, 2027, with the vesting percentage determined based on actual performance.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	17,700	Reported balance Holding disclosure · report date 2026-09-30 · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · Balance 17,700 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F5: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2025- December 31, 2027. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 27, 2028, with the vesting percentage determined based on actual performance.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	3,540	Reported balance Holding disclosure · report date 2026-09-30 · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · Balance 3,540 F4: Each restricted stock unit represents the right to receive, at settlement, one share of class B stock. F5: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2025- December 31, 2027. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 27, 2028, with the vesting percentage determined based on actual performance.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	7,675	Reported balance Holding disclosure · report date 2026-09-30 · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · Balance 7,675 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F6: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2026- December 31, 2028. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 19, 2029, with the vesting percentage determined based on actual performance.
Restricted Stock UnitSEC Table II · derivative / convertible security	Direct	1,535	Reported balance Holding disclosure · report date 2026-09-30 · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · Balance 1,535 F4: Each restricted stock unit represents the right to receive, at settlement, one share of class B stock. F6: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2026- December 31, 2028. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 19, 2029, with the vesting percentage determined based on actual performance.

Filing footnotes · ownership attribution and instrument terms

F1: Acquired shares via exercise of subscription agreement under Employee Stock Purchase Plan.

F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F3: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024- December 31, 2026. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 22, 2027, with the vesting percentage determined based on actual performance.

F4: Each restricted stock unit represents the right to receive, at settlement, one share of class B stock.

F5: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2025- December 31, 2027. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 27, 2028, with the vesting percentage determined based on actual performance.

F6: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2026- December 31, 2028. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 19, 2029, with the vesting percentage determined based on actual performance.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
September 30, 2018 Filed Oct 1, 2018 20:42 UTC	ASTRONICS CORP ATRO · Entity 4200	Grant$.01 PV Common Stock	829	$25.63	$21,247.27	Disclosure SEC source: 0001209191-18-052810 · doc4.xml · nonDerivative · entry 1 Mulato James · CIK 0001693402 · Pres Astronics Test Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,411 F1 · kind: Acquired shares via exercise of subscription agreement under Employee Stock Purchase Plan. Read SEC document
March 01, 2018 Filed Mar 5, 2018 22:00 UTC	ASTRONICS CORP ATRO · Entity 4200	GrantRestricted Stock Unit · Derivative	2,175	$0.00	$0.00	Disclosure SEC source: 0001209191-18-016575 · doc4.xml · derivative · entry 13 Mulato James · CIK 0001693402 · Pres Astronics Test Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175 Underlying: $.01 PV Com Stk · 2,175 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · derivative.exercise_date: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period of January 1, 2018- December 31, 2020. The "target" number of restricted stock units is reported. Between 75% and 115% of the target number of units may vest on December 31, 2020, with the vesting percentage determined based on actual performance. F3 · derivative.expiration_date: Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period of January 1, 2018- December 31, 2020. The "target" number of restricted stock units is reported. Between 75% and 115% of the target number of units may vest on December 31, 2020, with the vesting percentage determined based on actual performance. Read SEC document
December 12, 2017 Filed Dec 14, 2017 21:16 UTC	ASTRONICS CORP ATRO · Entity 4200	GrantOption · Derivative	7,950	$40.95 Strike: $40.95	$325,552.50	Disclosure SEC source: 0001209191-17-065681 · doc4.xml · derivative · entry 12 Mulato James · CIK 0001693402 · Pres Astronics Test Systems 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,950 Underlying: $.01 PV Com Stk · 7,950 shares Expires 2027-12-12 F2 · kind: Granted pursuant to the Astronics Corporation 2017 Long Term Incentive Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.